| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,679 |
1,579 |
$93K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
660 |
658 |
$29K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
251 |
242 |
$26K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
401 |
398 |
$20K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
357 |
343 |
$8K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
91 |
91 |
$8K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
815 |
815 |
$7K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
451 |
451 |
$5K |
| 90461 |
|
52 |
52 |
$1K |
| 96127 |
|
99 |
99 |
$1K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
12 |
12 |
$994.32 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
52 |
51 |
$685.73 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
15 |
15 |
$464.25 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
12 |
12 |
$292.01 |
| 92552 |
|
12 |
12 |
$195.72 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
14 |
14 |
$170.94 |
| 99000 |
|
108 |
103 |
$108.00 |
| 36415 |
Collection of venous blood by venipuncture |
42 |
41 |
$93.24 |